Related references
Note: Only part of the references are listed.Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
William M. Pardridge
BIOCONJUGATE CHEMISTRY (2008)
Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer
Yun Zhang et al.
PHARMACEUTICAL RESEARCH (2008)
Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Glycosylation-independent taraetina enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice
JH LeBowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug
M de Graaf et al.
BRITISH JOURNAL OF CANCER (2002)
Interactions of IGF-1 with the blood-brain barrier in vivo and in situ
WH Pan et al.
NEUROENDOCRINOLOGY (2000)
Share Paper
